Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Relapsed or Refractory Multiple Myeloma
NCT00241371Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2005
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in multiple myeloma (MM), sponsored by Washington University School of Medicine. Started Mar 2005; status: terminated.
02
Drugs
clofarabine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00241371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241371.